LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 2996 | 3925 | 0.7639 | 0.6790 |
BT-20 | Pictilisib | 10 | uM | LJP6 | 72 | hr | 1334 | 1307 | 3925 | 0.3333 | -0.0146 |
BT-20 | PD184352 | 0.04 | uM | LJP5 | 72 | hr | 1334 | 4104 | 4033 | 1.0175 | 1.0213 |
BT-20 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4079 | 4033 | 1.0116 | 1.0145 |
BT-20 | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3994 | 4033 | 0.9907 | 0.9885 |
BT-20 | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4044 | 4033 | 1.0039 | 1.0049 |
BT-20 | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4021 | 4033 | 0.9973 | 0.9969 |
BT-20 | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3389 | 4033 | 0.8410 | 0.7946 |
BT-20 | PLX-4720 | 10 | uM | LJP5 | 72 | hr | 1334 | 2460 | 4033 | 0.6103 | 0.4672 |
BT-20 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3896 | 3925 | 0.9925 | 0.9898 |
BT-20 | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 4110 | 3925 | 1.0473 | 1.0603 |
BT-20 | Lapatinib | 10 | uM | LJP6 | 72 | hr | 1334 | 3645 | 3925 | 0.9287 | 0.9070 |
BT-20 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1334 | 2522 | 3925 | 0.6426 | 0.5052 |
BT-20 | Sirolimus | 10 | uM | LJP6 | 72 | hr | 1334 | 2748 | 3925 | 0.7002 | 0.5907 |
BT-20 | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 1334 | 3845 | 3925 | 0.9790 | 0.9708 |
BT-20 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3685 | 3925 | 0.9387 | 0.9199 |
BT-20 | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 2264 | 3925 | 0.5775 | 0.4007 |
BT-20 | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 1334 | 3739 | 4033 | 0.9270 | 0.9067 |
BT-20 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3931 | 4033 | 0.9751 | 0.9688 |
BT-20 | BX-912 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3950 | 4033 | 0.9794 | 0.9736 |
BT-20 | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3578 | 4033 | 0.8876 | 0.8559 |
BT-20 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3848 | 3925 | 0.9801 | 0.9729 |
BT-20 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3880 | 3925 | 0.9882 | 0.9838 |
BT-20 | AZD-6482 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 2794 | 4033 | 0.6937 | 0.5901 |
BT-20 | AZD-6482 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3487 | 4033 | 0.8649 | 0.8263 |